Patents Assigned to Institute of Pharmacology, West China University of Medical Sciences
  • Bone resorption inhibition/osteogenesis promotion compound
    Patent number: 6028207
    Abstract: A compound represented by the following formula (I):X--Y--Z (I)where Y is represented by the following formulae: ##STR1## X is a monovalent group of a tetracycline type compounds and Z is a monoent group of a steroid type compound such as estrogen.The compound can concentrate on the bone tissue and has bone resorption inhibition/ossification promotion functions.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: February 22, 2000
    Assignees: Iskra Industry Co., Ltd., Institute of Pharmacology, West China University of Medical Sciences
    Inventors: Hu Zheng, Lingling Weng